|
Gene: INPP5K |
Gene summary for INPP5K |
Gene summary. |
Gene information | Species | Human | Gene symbol | INPP5K | Gene ID | 51763 |
Gene name | inositol polyphosphate-5-phosphatase K | |
Gene Alias | MDCCAID | |
Cytomap | 17p13.3 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q9BT40 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51763 | INPP5K | LZE4T | Human | Esophagus | ESCC | 4.90e-08 | 3.18e-01 | 0.0811 |
51763 | INPP5K | LZE7T | Human | Esophagus | ESCC | 2.33e-04 | 1.95e-01 | 0.0667 |
51763 | INPP5K | LZE8T | Human | Esophagus | ESCC | 1.09e-07 | 1.18e-01 | 0.067 |
51763 | INPP5K | LZE21D1 | Human | Esophagus | HGIN | 2.29e-02 | 2.25e-01 | 0.0632 |
51763 | INPP5K | LZE22T | Human | Esophagus | ESCC | 1.29e-03 | 2.91e-01 | 0.068 |
51763 | INPP5K | LZE24T | Human | Esophagus | ESCC | 2.28e-22 | 6.12e-01 | 0.0596 |
51763 | INPP5K | LZE21T | Human | Esophagus | ESCC | 2.00e-06 | 2.50e-01 | 0.0655 |
51763 | INPP5K | P1T-E | Human | Esophagus | ESCC | 9.00e-13 | 6.12e-01 | 0.0875 |
51763 | INPP5K | P2T-E | Human | Esophagus | ESCC | 1.12e-22 | 3.52e-01 | 0.1177 |
51763 | INPP5K | P4T-E | Human | Esophagus | ESCC | 4.96e-13 | 3.60e-01 | 0.1323 |
51763 | INPP5K | P5T-E | Human | Esophagus | ESCC | 1.04e-05 | 9.09e-02 | 0.1327 |
51763 | INPP5K | P8T-E | Human | Esophagus | ESCC | 7.15e-18 | 3.48e-01 | 0.0889 |
51763 | INPP5K | P9T-E | Human | Esophagus | ESCC | 1.54e-13 | 3.86e-01 | 0.1131 |
51763 | INPP5K | P10T-E | Human | Esophagus | ESCC | 2.09e-32 | 4.56e-01 | 0.116 |
51763 | INPP5K | P11T-E | Human | Esophagus | ESCC | 8.79e-14 | 5.25e-01 | 0.1426 |
51763 | INPP5K | P12T-E | Human | Esophagus | ESCC | 1.57e-29 | 4.78e-01 | 0.1122 |
51763 | INPP5K | P15T-E | Human | Esophagus | ESCC | 1.20e-09 | 1.81e-01 | 0.1149 |
51763 | INPP5K | P16T-E | Human | Esophagus | ESCC | 4.00e-25 | 4.72e-01 | 0.1153 |
51763 | INPP5K | P17T-E | Human | Esophagus | ESCC | 9.80e-12 | 4.11e-01 | 0.1278 |
51763 | INPP5K | P19T-E | Human | Esophagus | ESCC | 1.69e-13 | 6.96e-01 | 0.1662 |
Page: 1 2 3 4 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003223120 | Esophagus | ESCC | regulation of actin filament bundle assembly | 64/8552 | 105/18723 | 1.15e-03 | 5.70e-03 | 64 |
GO:00442827 | Esophagus | ESCC | small molecule catabolic process | 201/8552 | 376/18723 | 1.35e-03 | 6.41e-03 | 201 |
GO:00353056 | Esophagus | ESCC | negative regulation of dephosphorylation | 31/8552 | 45/18723 | 1.40e-03 | 6.62e-03 | 31 |
GO:00109065 | Esophagus | ESCC | regulation of glucose metabolic process | 71/8552 | 119/18723 | 1.46e-03 | 6.92e-03 | 71 |
GO:003582114 | Esophagus | ESCC | modulation of process of other organism | 64/8552 | 106/18723 | 1.61e-03 | 7.50e-03 | 64 |
GO:005149225 | Esophagus | ESCC | regulation of stress fiber assembly | 56/8552 | 91/18723 | 1.66e-03 | 7.68e-03 | 56 |
GO:00061096 | Esophagus | ESCC | regulation of carbohydrate metabolic process | 101/8552 | 178/18723 | 1.89e-03 | 8.52e-03 | 101 |
GO:005170214 | Esophagus | ESCC | biological process involved in interaction with symbiont | 57/8552 | 94/18723 | 2.46e-03 | 1.07e-02 | 57 |
GO:00439224 | Esophagus | ESCC | negative regulation by host of viral transcription | 12/8552 | 14/18723 | 2.51e-03 | 1.08e-02 | 12 |
GO:00512244 | Esophagus | ESCC | negative regulation of protein transport | 74/8552 | 127/18723 | 2.86e-03 | 1.21e-02 | 74 |
GO:19049505 | Esophagus | ESCC | negative regulation of establishment of protein localization | 76/8552 | 131/18723 | 2.96e-03 | 1.24e-02 | 76 |
GO:00323875 | Esophagus | ESCC | negative regulation of intracellular transport | 37/8552 | 58/18723 | 4.12e-03 | 1.64e-02 | 37 |
GO:00106755 | Esophagus | ESCC | regulation of cellular carbohydrate metabolic process | 83/8552 | 146/18723 | 4.24e-03 | 1.69e-02 | 83 |
GO:003103219 | Esophagus | ESCC | actomyosin structure organization | 108/8552 | 196/18723 | 4.86e-03 | 1.88e-02 | 108 |
GO:00302586 | Esophagus | ESCC | lipid modification | 116/8552 | 212/18723 | 4.90e-03 | 1.89e-02 | 116 |
GO:00903174 | Esophagus | ESCC | negative regulation of intracellular protein transport | 28/8552 | 42/18723 | 4.90e-03 | 1.89e-02 | 28 |
GO:011002025 | Esophagus | ESCC | regulation of actomyosin structure organization | 59/8552 | 100/18723 | 4.98e-03 | 1.91e-02 | 59 |
GO:00331355 | Esophagus | ESCC | regulation of peptidyl-serine phosphorylation | 81/8552 | 144/18723 | 6.79e-03 | 2.48e-02 | 81 |
GO:0039692 | Esophagus | ESCC | single stranded viral RNA replication via double stranded DNA intermediate | 15/8552 | 20/18723 | 7.60e-03 | 2.71e-02 | 15 |
GO:00903132 | Esophagus | ESCC | regulation of protein targeting to membrane | 24/8552 | 36/18723 | 8.98e-03 | 3.13e-02 | 24 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
INPP5K | deletion | Frame_Shift_Del | novel | c.415delN | p.Tyr139MetfsTer55 | p.Y139Mfs*55 | Q9BT40 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
INPP5K | SNV | Missense_Mutation | novel | c.258C>G | p.Ile86Met | p.I86M | Q9BT40 | protein_coding | deleterious(0.01) | possibly_damaging(0.756) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
INPP5K | SNV | Missense_Mutation | rs138972043 | c.1259N>A | p.Arg420His | p.R420H | Q9BT40 | protein_coding | tolerated(0.65) | benign(0.001) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
INPP5K | SNV | Missense_Mutation | c.809N>A | p.Arg270His | p.R270H | Q9BT40 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
INPP5K | SNV | Missense_Mutation | rs779661934 | c.212N>T | p.Ser71Leu | p.S71L | Q9BT40 | protein_coding | deleterious(0.02) | benign(0.028) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
INPP5K | SNV | Missense_Mutation | c.809G>A | p.Arg270His | p.R270H | Q9BT40 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-F4-6856-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Ancillary | leucovorin | CR | |
INPP5K | SNV | Missense_Mutation | c.112C>A | p.Leu38Met | p.L38M | Q9BT40 | protein_coding | deleterious(0.01) | probably_damaging(0.984) | TCGA-AF-6672-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Ancillary | leucovorin | PD | |
INPP5K | SNV | Missense_Mutation | novel | c.239N>C | p.Leu80Pro | p.L80P | Q9BT40 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
INPP5K | SNV | Missense_Mutation | rs756203232 | c.1258N>T | p.Arg420Cys | p.R420C | Q9BT40 | protein_coding | deleterious(0.01) | possibly_damaging(0.513) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
INPP5K | SNV | Missense_Mutation | novel | c.989N>C | p.Leu330Pro | p.L330P | Q9BT40 | protein_coding | tolerated(0.07) | benign(0.027) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |